Contribution of Substance Use Disorders on HIV Treatment Outcomes and Antiretroviral Medication Adherence Among HIV-Infected Persons Entering Jail

被引:48
|
作者
Chitsaz, Ehsan [1 ]
Meyer, Jaimie P. [1 ]
Krishnan, Archana [1 ]
Springer, Sandra A. [1 ]
Marcus, Ruthanne [1 ]
Zaller, Nick [2 ]
Jordan, Alison O. [3 ]
Lincoln, Thomas [4 ]
Flanigan, Timothy P. [2 ]
Porterfield, Jeff [5 ]
Altice, Frederick L. [1 ,6 ]
机构
[1] Yale Univ, Sch Med, AIDS Program, Infect Dis Sect, New Haven, CT 06510 USA
[2] Brown Univ, Sch Med, Providence, RI 02912 USA
[3] New York City Dept Hlth & Mental Hyg, Correct Hlth Serv, New York, NY USA
[4] Baystate Med Ctr, Springfield, MA USA
[5] AID Atlanta, Atlanta, GA USA
[6] Yale Univ, Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT 06510 USA
关键词
Substance abuse; Jail; Prisoners; Engagement in HIV care; Antiretroviral therapy; Adherence; Criminal justice; ADDICTION SEVERITY INDEX; PUBLIC-HEALTH; CARE; THERAPY; ABUSE; PRISONERS; OPPORTUNITY; PREVENTION; STRATEGIES; COMMUNITY;
D O I
10.1007/s10461-013-0506-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
HIV and substance use are inextricably intertwined. One-sixth of people living with HIV/AIDS (PLWHA) transition through the correctional system annually. There is paucity of evidence on the impact of substance use disorders on HIV treatment engagement among jail detainees. We examined correlates of HIV treatment in the largest sample of PLWHA transitioning through jail in 10 US sites from 2007 to 2011. Cocaine, alcohol, cannabis, and heroin were the most commonly used substances. Drug use severity was negatively and independently correlated with three outcomes just before incarceration: (1) having an HIV care provider (AOR = 0.28; 95 % CI 0.09-0.89); (2) being prescribed antiretroviral therapy (AOR = 0.12; 95 % CI 0.04-0.35) and (3) high levels (>95 %) of antiretroviral medication adherence (AOR = 0.18; 95 % CI 0.05-0.62). Demographic, medical and psychiatric comorbidity, and social factors also contributed to poor outcomes. Evidence-based drug treatments that include multi-faceted interventions, including medication-assisted therapies, are urgently needed to effectively engage this vulnerable population.
引用
收藏
页码:118 / 127
页数:10
相关论文
共 50 条
  • [41] Psychiatric Disorders, Antiretroviral Medication Adherence and Viremia in a Cohort of Perinatally HIV-Infected Adolescents and Young Adults
    Bucek, Amelia
    Leu, Cheng-Shiun
    Benson, Stephanie
    Warne, Patricia
    Abrams, Elaine J.
    Elkington, Katherine S.
    Dolezal, Curtis
    Wiznia, Andrew
    Mellins, Claude Ann
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (07) : 673 - 677
  • [42] Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders
    Mellins, Claude Ann
    Havens, Jennifer F.
    McDonnell, Cheryl
    Lichtenstein, Carolyn
    Uldall, Karina
    Chesney, Margaret
    Santamaria, E. Karina
    Bell, James
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2009, 21 (02): : 168 - 177
  • [43] Feasibility and Acceptability of a Smartphone App for Daily Reports of Substance Use and Antiretroviral Therapy Adherence among HIV-Infected Adults
    Przybyla, Sarahmona M.
    Eliseo-Arras, Rebecca K.
    Krawiec, Gabriela
    Gower, Emily
    Dermen, Kurt
    [J]. AIDS RESEARCH AND TREATMENT, 2016, 2016
  • [44] Effects of Antidepressant Treatment on Antiretroviral Regimen Adherence Among Depressed HIV-Infected Patients
    Virender Kumar
    William Encinosa
    [J]. Psychiatric Quarterly, 2009, 80 : 131 - 141
  • [45] Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients
    Yun, LWH
    Maravi, M
    Kobayashi, JS
    Barton, PL
    Davidson, AJ
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (04) : 432 - 438
  • [46] Effects of Antidepressant Treatment on Antiretroviral Regimen Adherence Among Depressed HIV-Infected Patients
    Kumar, Virender
    Encinosa, William
    [J]. PSYCHIATRIC QUARTERLY, 2009, 80 (03) : 131 - 141
  • [47] Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons
    Turner, BJ
    Fleishman, JA
    Wenger, N
    London, AS
    Burnam, MA
    Shapiro, MF
    Bing, EG
    Stein, MD
    Longshore, D
    Bozzette, SA
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2001, 16 (09) : 625 - 633
  • [48] Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons
    Barbara J. Turner
    John A. Fleishman
    Neil Wenger
    Andrew S. London
    M. Audrey Burnam
    Martin F. Shapiro
    Eric G. Bing
    Michael D. Stein
    Douglas Longshore
    Samuel A. Bozzette
    [J]. Journal of General Internal Medicine, 2001, 16 : 625 - 633
  • [49] Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons
    Ammassari, A
    Antinori, A
    Aloisi, MS
    Trotta, MP
    Murri, R
    Bartoli, L
    Monforte, AD
    Wu, AW
    Starace, F
    [J]. PSYCHOSOMATICS, 2004, 45 (05) : 394 - 402
  • [50] Results of early antiretroviral therapy and mortality among HIV-Infected persons
    Krasnov, M.
    Cherkasov, A.
    Kojevnikova, I
    Velykodanov, G.
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 105 - 105